Genetic testing not cost-effective in guiding initial dosing of common blood thinner
Thursday, January 22, 2009 - 15:21
in Health & Medicine
New analyses led by the University of Cincinnati (UC) show that genetic testing used to guide initial dosing of the blood-thinner warfarin may not be cost-effective for typical patients with atrial fibrillation but may be for patients at higher risk for major bleeding...